First Time Loading...

Jinghua Pharmaceutical Group Co Ltd
SZSE:002349

Watchlist Manager
Jinghua Pharmaceutical Group Co Ltd Logo
Jinghua Pharmaceutical Group Co Ltd
SZSE:002349
Watchlist
Price: 7.42 CNY 1.37% Market Closed
Updated: Jun 1, 2024

Jinghua Pharmaceutical Group Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jinghua Pharmaceutical Group Co Ltd
Research & Development Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Jinghua Pharmaceutical Group Co Ltd
SZSE:002349
Research & Development
-¥68.5m
CAGR 3-Years
-6%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Research & Development
-¥4.8B
CAGR 3-Years
-19%
CAGR 5-Years
-29%
CAGR 10-Years
-56%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Research & Development
-¥2.1B
CAGR 3-Years
-19%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Research & Development
-¥228.3m
CAGR 3-Years
-37%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Research & Development
-¥5B
CAGR 3-Years
3%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Research & Development
-¥329.2m
CAGR 3-Years
-21%
CAGR 5-Years
-30%
CAGR 10-Years
N/A

See Also

What is Jinghua Pharmaceutical Group Co Ltd's Research & Development?
Research & Development
-68.5m CNY

Based on the financial report for Mar 31, 2024, Jinghua Pharmaceutical Group Co Ltd's Research & Development amounts to -68.5m CNY.

What is Jinghua Pharmaceutical Group Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-16%

Over the last year, the Research & Development growth was 20%. The average annual Research & Development growth rates for Jinghua Pharmaceutical Group Co Ltd have been -6% over the past three years , -16% over the past five years .